Suppliers of microbiology consumables and equipment are discussed in terms of market share, product types, and geography. Specific consumables and equipment are almost universal to the microbiology market, but many tools are sector-specific, and this report will highlight the differences.
This report will not focus on antimicrobial compounds, either for pharmaceutical or sterilization purposes, but will focus on microbial detection methods when applicable. It will not provide a particular focus on the intersection of pharmaceuticals and microbiology, as this is beyond its scope.
Report Includes
- 27 tables
- An up-to-date review and analysis of the global markets for microbiology-based equipment and consumables
- Analyses of the global market trends, with market revenue data from 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Highlights of key market potential for microbiology consumables and equipment, technological trends, opportunities, and gaps estimating the current and future demand for microbial technologies market and its sub-segments
- Estimation of the actual market size and revenue forecast for global microbiology market in USD million values, and corresponding market share analysis based on technology type, application, end user and region
- Coverage of the technological, economic, and business considerations of global microbiology market, with analyses and growth forecasts through 2027
- Discussion of market dynamics that impact the growth of the market for microbiology consumables and equipment, clinical applications, market regulations, industry structure, and penetration of technologies within the biotech industry
- Competitive landscape of the key manufacturers and suppliers of the microbiology market, their product portfolios, financial updates, and major growth strategies within the marketplace
- Descriptive company profiles of leading industry players, including Abbott, BD, Bio-Rad Laboratories Inc., Johnson & Johnson, Sanofi SA and Thermo Fisher Scientific Inc.
Table of Contents
Chapter 1 Introduction
1.1 Study Goals and Objectives
1.2 Scope of Report
1.3 Reasons for Doing this Study
1.4 What's New in this Update?
1.5 Information Sources and Methodology
1.5.1 Secondary Research
1.5.2 Primary Research
1.6 Methodology
1.7 Geographic Breakdown
1.8 Analyst's Credentials
1.9 Custom Research
1.10 Related Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Evaluation of the Market Based on Technology
3.1 Overview
3.2 Application Industries
3.2.1 Academia
3.2.2 Government
3.2.3 Public Health
3.2.4 Regulatory
3.2.5 Industry
3.2.6 Clinical
3.2.7 Pharmaceutical
3.2.8 Environmental
3.2.9 Manufacturing
3.2.10 Energy
3.2.11 Food
3.3 Uses
3.3.1 Clinical
3.3.2 Environmental Microbiology
3.3.3 Epidemiology
3.3.4 Product Manufacturing
3.3.5 Energy
3.3.6 Industrial Microbiology
Chapter 4 Market by Segment
4.1 Consumables
4.2 Equipment
4.2.1 Bioreactors
4.3 Automation and Technology
4.3.1 Walkaways and Automated Detection
4.3.2 High-Throughput Systems
4.3.3 Molecular Testing
4.3.4 Microbes
Chapter 5 Impact of the Covid-19 Pandemic
5.1 Overview
5.2 Outbreak
5.3 Symptoms of Covid-19
5.4 Progression of Covid-19
5.5 Incubation Period
5.6 Epidemiology
5.6.1 Collaboration Between Organizations and Governments
5.6.2 Spread of Disease
5.7 Current Status and Impact on Medical Technology
5.7.1 Elective and Noncritical Procedures
5.7.2 Shift in Manufacturing
5.7.3 Regulatory Delays, Clinical Trials, and Product Launches
5.7.4 Supply Chain Disruptions
5.7.5 Medical Tourism
Chapter 6 Evaluation of Infectious Diseases
6.1 Overview
6.2 Public Health Reportable Infectious Diseases
6.3 Nonpublic Health Reportable Infectious Diseases
Chapter 7 Evaluation of the Market Based on Region
7.1 Overview of the Geographical Distribution of the Market
7.1.1 North America
7.1.2 Europe
7.1.3 Asia-Pacific
7.1.4 Rest of the World (Row)
7.2 Summary of the Market for Microbiological Automation by Region
Chapter 8 Competitive Analysis
8.1 Overview
8.2 Diagnostics
8.3 Environment
8.4 Industrial
8.5 Regulatory
Chapter 9 Patents/Clinical Trails
Chapter 10 Technology Review
10.1 Overview
10.2 Gut Microbiology
10.3 Public Health Emergencies
10.4 Microbes in Solar Cells
10.5 Trends in Antibiotic Resistance
10.6 Impact on Future Clinical Microbiology Developments
Chapter 11 Company Profiles
- 3M
- Abbott
- Abbvie Inc.
- Agilent Technologies Inc.
- B. Braun Melsungen AG
- Bd
- Biomerieux Sa
- Bio-Rad Laboratories Inc.
- Boston Scientific Corp.
- Cosmed Pharmaceutical Co. Ltd.
- F. Hoffmann-La Roche Ltd.
- Genmark Diagnostics Inc.
- Johnson & Johnson Services Inc.
- Medtronic Inc.
- Quest Diagnostics
- Sanofi Sa
- Siemens Healthineers
- Smith & Nephew plc
- Stryker Corp.
- Terumo Corp.
- Thermo Fisher Scientific Inc.
List of Tables
Summary Table: Global Market for Microbiological Technology, Equipment and Consumables, by Region, Through 2027
Table 1: Global Market for Microbiological Consumables, by Segment, Through 2027
Table 2: Global Market for Microbiological Consumable Vessels, Through 2027
Table 3: Global Market for Microbiological Media, Through 2027
Table 4: Global Market for Microbiological Reagents and Other Consumables, Through 2027
Table 5: Global Market for Microbiological Equipment, by Type, Through 2027
Table 6: Global Market for Microbiological Bioreactors, by Subsegment, Through 2027
Table 7: Global Market for Microbiological Walkaway and Automated Detection, Through 2027
Table 8: Global Market for Microbiological High-throughput Systems, Through 2027
Table 9: Global Market for Microbiological Molecular Testing, Through 2027
Table 10: Global Market for Microbiological Microbes, Through 2027
Table 11: Distribution of COVID-19 Clinical Symptoms
Table 12: Global Market for Microbiological Automation, by Region, Through 2027
Table 13: Global Market for Microbiological Consumables, by Region, Through 2027
Table 14: Examples of Patents and Patent Applications Filed on Microbiological Technology, Equipment and Consumables
Table 15: BD: Key Developments
Table 16: BD: Business Segments
Table 17: BD: COVID-19 Diagnostics
Table 18: BioMérieux SA: Products and Services
Table 19: Bio-Rad Laboratories: Products and Services
Table 20: Bio-Rad Laboratories: SARS-CoV-2/COVID-19 Diagnosis and Confirmation Solutions
Table 21: F. Hoffmann-La Roche: Product Portfolio
Table 22: F. Hoffmann-La Roche: COVID-19 Diagnostics
Table 23: GenMark Diagnostics: COVID-19 Diagnostics
Table 24: Siemens Healthineers: Product Portfolio
Table 25: Smith & Nephew: Combination Products
Table 26: Thermo Fisher Scientific: Product Portfolio
List of Figures
Summary Figure: Global Market for Microbiological Technology, Equipment and Consumables, by Segment, 2019-2027
Figure 1: Global Market for Microbiological Incubators and Culture Apparatus, 2019-2027
Figure 2: Global Market for Microbiological Bioreactors, 2019-2027
Figure 3: Global Market for Microbiological Automation, 2019-2027
Figure 4: Snapshot of Global Market for Microbiological Technology, Equipment and Consumables, by Region
Figure 5: Global Market for Microbiological Technology, Equipment and Consumables, by Region, 2019-2027
Figure 6: Global Market for Microbiological Equipment, by Region, 2019-2027
Figure 7: Agilent: Annual Revenue, 2020-2022
Samples
LOADING...
Executive Summary
Growth in the market has historically resulted from increased health care expenditure, emerging market growth, rapid technological advances, rapid growth in the aging population, and the emergence of novel pathogenic infections. Factors that have negatively affected the market include regulatory challenges, political uncertainties, reduction in free trade, and low health care reimbursements.
In the future, increased funding, the aging population, greater access to health care, and a rapid rise in various bacterial and viral epidemics will drive the growth of the market. Factors that could hinder the microbiology diagnostic device and equipment market in the future include a need for more skilled/trained microbiologists and flawed and outdated health systems.
Market trend-based strategies for the microbiology diagnostic device and equipment market include the growing adoption of predictive diagnostics, automation in microbiology diagnostics, next-generation microbial testing, and increasing mergers and strategic acquisitions. Market players have also focused on new product developments and innovative product launches. To take advantage of opportunities, microbiology diagnostic device and equipment companies should increase their adoption of predictive diagnostics, focus on automation in microbiology diagnostics, focus more on next-generation microbial testing, expand in emerging markets, provide competitively priced offerings, participate in trade shows and events, and grow partnerships with end users.
North America leads the global microbiological technology, equipment and consumables market, followed by Europe. However, Asia-Pacific is expected to witness the highest growth over the next five years.
In summary, the current microbiological technology, equipment and consumables market was analyzed and evaluated to provide forecasts and outline possible outcomes for the next five years in different areas of the industry. This report also highlights new trends, patent activity, and other market-related developments.
The following summary table shows the value of the microbiological technology, equipment and consumables market in different geographical regions.
Companies Mentioned
- 3M
- Abbott
- Abbvie Inc.
- Agilent Technologies Inc.
- B. Braun Melsungen AG
- Bd
- Biomerieux Sa
- Bio-Rad Laboratories Inc.
- Boston Scientific Corp.
- Cosmed Pharmaceutical Co. Ltd.
- F. Hoffmann-La Roche Ltd.
- Genmark Diagnostics Inc.
- Johnson & Johnson Services Inc.
- Medtronic Inc.
- Quest Diagnostics
- Sanofi Sa
- Siemens Healthineers
- Smith & Nephew plc
- Stryker Corp.
- Terumo Corp.
- Thermo Fisher Scientific Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 101 |
| Published | February 2023 |
| Forecast Period | 2022 - 2027 |
| Estimated Market Value ( USD | $ 5.6 Billion |
| Forecasted Market Value ( USD | $ 8.5 Billion |
| Compound Annual Growth Rate | 8.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
